Anonymous
Guest
Anonymous
Guest
WTF, bait and switch. Averaging down the pay rate and increasing the goal from 50 to 100. Here is the scenerio. Hit goal at 50 syringes= $7500. About 300 (65%) did not even sell 50...wake up!!! Now Q2, Amgen wants: 100% growth (50) and 100% repeat injections(50). Not even realistic using the latest VP report.
The low performers gets a break that they don't have to pay back Amgen by zeroing out their bonus for Q2. That is bull since it is being covered by the top performers by reducing their rate of payout. Demotivating!
Hibernating for Q2!
The low performers gets a break that they don't have to pay back Amgen by zeroing out their bonus for Q2. That is bull since it is being covered by the top performers by reducing their rate of payout. Demotivating!
Hibernating for Q2!